At Johnson & Johnson, we conduct business according to the values embodied in Our Credo. We operate with the highest standards regarding our employees, the environment, the patients and consumers we serve, and all other stakeholders. The guidelines and policies, statements and standards below define what we expect of ourselves, and our business partners, as we operate with integrity throughout the world.
Diversity and Inclusion Policy
Johnson & Johnson and all its operating companies are committed to workplace diversity and to cultivating, fostering and preserving a culture of inclusion. We know that bringing our diverse backgrounds, cultures, and perspectives together is the way to solve today’s complex health problems. Our Credo outlines our responsibility to create an inclusive environment and to respect the dignity and diversity of all people. This makes diversity and inclusion (D&I) everyone’s responsibility—that of every employee around the globe. Enabling everyone at Johnson & Johnson to perform at their best while being themselves is fundamental to our continued success.
Our most important resource is our employees. All employment must be in compliance with all applicable laws and regulations, including those concerning hours, compensation, equal opportunity, human rights and working conditions.
Guide for Resolving Employee Disagreements – North America
The Johnson & Johnson Family of Companies has exceptionally productive and creative workforces. Our employees are our most valuable asset and have helped establish the Johnson & Johnson Family of Companies as a leader in the healthcare field.
Our Company has worked hard to build a reputation for responsible behavior and fairness—a reputation that fosters trust with our customers, employees, community leaders and shareholders. We can continue to build trust only if we are steadfast in our focus on improving all aspects of Our Credo responsibilities, including the quality of our work environment. This philosophy is embodied in Our Credo and in our Policy on providing a workplace free of harassment and bullying.
At Johnson & Johnson, we are a company guided by Our Credo, and, our employees are the heart, mind and soul of the Company. We are committed to helping employees, their families and communities live well across their whole lives—spiritual, mental, emotional, physical and financial—enabling an engaged, purpose-driven workforce that improves health for humanity.
In addition to Johnson & Johnson’s own employment policies, the Company requires that all suppliers abide by the following policy on the employment of persons under the age of 18 (“young persons”) in the manufacture of any product, or any component of a product, by or for Johnson & Johnson or any of its affiliates worldwide.
Our Credo is the foundation for our Climate Friendly Energy Policy. It provides us with a clear, compelling and enduring reminder of our responsibilities. Our Credo states we must be good citizens in the global community; we must protect the environment and natural resources; and we must strive to reduce costs in order to maintain reasonable prices. We are committed to excellence in fostering the efficient, cost‐effective, and environmentally responsible purchasing and use of energy.
Our Credo is the foundation of our Environment, Health and Safety (EHS) Policy. It provides us with a clear, compelling and enduring reminder of our responsibilities to mothers, fathers, doctors, nurses and caregivers, employees, communities, and shareholders. Our Credo states we must ensure working conditions are clean, orderly and safe; encourage better health and education; and maintain in good order the property we are privileged to use, protecting the environment and natural resources.
Impact of Pharmaceuticals and Personal Care Products in the Environment
The pharmaceutical and personal care industries recognize the concerns raised by stakeholders regarding the presence of pharmaceuticals in the environment (PIE) and personal care products in the environment (PCPE). The major source of pharmaceuticals entering the environment is via patient excretion following use of medicine that is taken to prevent, cure or alleviate a medical condition.
Biodiversity refers to the variety of life on earth, including diversity of ecosystems, genes and species, and ecological practices that support them.1 There is a growing concern about the loss of biodiversity and ecosystem services in many areas of the world, including the associated impacts on human health and economic development.
Johnson & Johnson is governed by the values set forth in Our Credo, created by General Robert Wood Johnson in 1943. These values have guided us for many years and will continue to set the tone of integrity for the entire Company. All of us at Johnson & Johnson, the employees, officers and Directors, are committed to the ethical principles embodied in Our Credo.
In order to deliver value to our patients, consumers, caregivers, employees, communities and shareholders, we at Johnson & Johnson must understand and manage the risks faced across our entire organization. Risks are inherent in our business activities and can relate to strategic goals, business performance, compliance with laws and regulations, and those critical to environmental, social and governance priorities. Read more about how Johnson & Johnson manages risk across the enterprise in our Enterprise Risk Management Framework.
At Johnson & Johnson, we are committed to responsible, ethical and patient-centered sales and marketing practices for our Consumer, Pharmaceutical and Medical Devices products and services. Our sales and marketing efforts seek to inform health decisions and consumer choices.
This policy implements U.S. federal requirements pertaining to “Objectivity in Research” promulgated by the Public Health System (“PHS”) of the U.S. Department of Health and Human Services (“HHS”), which includes the U.S. National Institutes of Health (“NIH”), the Biomedical Advanced Research and Development Authority (“BARDA”), the Center for Disease Control and Prevention, and the Agency for Healthcare Research and Quality (“FCOI Policy”).
Intellectual property (IP) protections provide a vital framework that enables the development of new, innovative and life-changing treatments, cures and other technologies for patients and consumers around the world. IP protections provide incentives that ensure innovative companies like Johnson & Johnson can continue to invest in cutting-edge research, especially given the high cost and time it takes to develop new medicines and treatments.
At Johnson & Johnson, we believe acting ethically and responsibly is not only the right thing to do, but also the right thing to do for our business. Our Johnson & Johnson Code of Business Conduct ensures that we hold ourselves and how we do business to a high standard, allowing us to fulfill our obligations to the many stakeholders we serve.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, crafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
Ensuring we deliver high quality products to our customers around the world and complying with the laws and regulations which govern our business activities have been long-standing principles at Johnson & Johnson. Adherence to these principles is the responsibility of every employee, and is critical to help protect and enhance the reputation of Johnson & Johnson.
The Johnson & Johnson Family of Companies has a long history of collaborating to fuel innovation. Our relationships with health care professionals have led to some of the most revolutionary developments in our history, enriching and saving millions of lives around the world.
Responsible Interaction with Health Care Professionals
Ethical relationships with health care professionals are a critical part of developing and marketing health care products. Physicians need to learn how to use new medicines and medical devices. Company representatives have an important role in teaching them about these products.
The Johnson & Johnson Family of Companies manages a variety of social media channels and strives to create informative, engaging, supportive communities where we can share information and have conversations.
Johnson & Johnson is committed to changing the course of human health for the better by remaining true to Our Credo and the principles we’ve embraced since our beginning. By being broadly based in healthcare and using our reach and size for good, we are working together to forge a healthier, more equitable future.
Statement on Interactions With Patient Organizations
In recent years, the role of the patient in the healthcare system has changed rapidly– from a recipient of care to an involved, educated and collaborative partner. As increasingly active owners of their own healthcare journeys, patients and their care teams are well-positioned to provide unique and valuable insights in every stage of the product lifecycle. This statement sets out the Johnson & Johnson Family of Companies (“Johnson & Johnson”) principles and approach for such interactions by the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”) and those working on behalf of Janssen and Johnson & Johnson.
Johnson & Johnson is strongly committed to protecting the privacy of those who entrust us with their personal information. Our customers, consumers, website visitors, employees, clinical research participants and all those who do business with us trust and expect that we will protect their personal information in accordance with the promises we make. Particularly in the area of personal health, individuals are rightly concerned that the privacy promises we make are honored to the fullest extent.
Johnson & Johnson believes it is our responsibility as a corporate citizen to pay our fair share of taxes, including corporate income taxes, employment taxes, social contributions, property taxes, import and customs duties, and indirect taxes.
Antimicrobial resistance (AMR) is one of the defining scientific, health and economic challenges of our time. Without urgent and meaningful action to address specific diseases and system-level issues, patients, families and communities around the world will face a tremendous threat in the years ahead from untreatable infections. While AMR is fundamentally driven by the ability of pathogens to evolve, its impact is greatly amplified by factors that span economic, healthcare and agricultural domains.
At Johnson & Johnson, we believe that good health is at the heart of human progress—it enables children to thrive, women to succeed, families and communities to prosper, and countries to rise from poverty and achieve economic security. That is why we have a promise to relentlessly drive better health for all.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we strive to discover and develop transformational medicines to help people around the world live longer, healthier and more productive lives. We are working with all our partners and stakeholders in health care to ensure broader access to medicines today, while sustaining the biomedical research ecosystem that is our best hope for defeating disease and transforming the lives of tomorrow’s patients.
California Transparency in Supply Chains Act & United Kingdom Modern Slavery Act Statement
This statement explains the steps that we have taken to help ensure that slavery and human trafficking is not taking place within the Johnson & Johnson Family of Companies (“Johnson & Johnson”) supply chain. Some countries and U.S. states have implemented legislation that requires certain businesses to provide public statements in this regard. This legislation includes the California Transparency in Supply Chains Act of 2010 and Part 6, Section 54 of the United Kingdom Modern Slavery Act of 2015. This annual statement1 is intended to provide our stakeholders with information that will allow them to make more informed decisions about the goods they are purchasing.
Johnson & Johnson strictly prohibits employees, subcontractors, subcontractor employees, and agents from engaging in human trafficking-related activities. These activities include engaging in sex trafficking, procuring commercial sex acts (even if this practice is legal in the jurisdiction where it transpires), using force, fraud, or coercion to subject a person to involuntary servitude, or obtaining labor from a person by threats of serious harm to that person or another person, among others.
At Johnson & Johnson, we are guided and sustained by a statement of beliefs we call Our Credo, which outlines our responsibilities to our customers, our employees, our communities around the world, as well as our shareholders. These responsibilities guide our business and social practices with a strong focus on the people, customers and communities we serve – not only in what we say, but in how we act as a Company.
Since its beginning, the Johnson & Johnson Family of Companies has been a pioneer in the research and development of new products, pharmaceuticals and medical devices that contribute to the health and well-being of people around the world. We strive to maintain an environment of innovative product development, conducting all phases of research and development to the highest ethical standard, while advancing pipelines that serve medical needs. Our investments in R&D are helping us continually deliver meaningful innovations for our customers.
Ethical Code for the Conduct of Research and Development
Our Ethical Code for the Conduct of Research and Development is intended to complement our Credo by providing more specific standards of conduct and behavior for physicians, clinical research scientists and others who are responsible for medical aspects of research and development.
Guidelines on Human Pluripotent Stem Cell Research
At Johnson & Johnson, Our Credo values are a constant guide to our decision making. They reinforce for us that the needs and well-being of the people we serve — patients and customers — must come first. We adhere to these values and maintain high ethical standards in our scientific research methods and programs. We also comply with the appropriate regulatory and industry guidelines as we seek to break new ground with advances in science and technology.
Johnson & Johnson is committed to ensure the ethical treatment of animals used in laboratory settings to advance patient safety and well-being. Johnson & Johnson operating companies have policies and guidelines in place that drive the ethical and humane treatment of the animals we use, and that promote the use of non-animal alternatives whenever feasible. We support and participate in efforts to obtain regulatory acceptance of alternative testing methods. Our standards for animal care and use are intended to meet or exceed all applicable regulations.
Supply Chain Transparency and Responsible Sourcing
Wood-Fiber Products Sourcing Criteria
As the world’s largest, most broadly-based healthcare company, Johnson & Johnson understands that human health is inextricably linked to environmental health—you can’t have healthy people without a healthy planet. This means that to create healthier societies, we must have an unwavering commitment to preserving our planet and the vital resources upon which we all rely, today and in the future.
At Johnson & Johnson, we hold ourselves to high standards, which reflect our internal values as well as the expectations of external stakeholders. In turn, we strive to work with suppliers who share our values because we believe that business relationships are most productive and effective when they are built on trust, mutual respect and a common commitment to operating responsibly and ethically.
At Johnson & Johnson, we are committed to doing our part to address the unsustainable rate of global deforestation, particularly in precious rain forests. We recognize and share other stakeholders’ concerns about the negative effect palm oil sourcing can have on the environment and local communities. We are committed to implementing our sourcing criteria across our top suppliers representing at least 85 percent of our volume by year-end 2020. Central to this commitment is the difficult task of improving transparency in our palm oil derivatives supply chains.
The Johnson & Johnson Family of Companies is committed to ensuring that it conducts its business worldwide with respect for human rights and in compliance with all applicable laws and fair labor practices, as evidenced by our Statement on Human Rights and our Responsibility Standards for Suppliers.
At Johnson & Johnson we believe our first responsibility is to the doctors, nurses and patients, mothers and fathers and all others who use our products. In today’s global economy, where patients and consumers may be exposed to counterfeit products of all kinds, we must take tangible steps to help ensure they receive the genuine products of the Johnson & Johnson Family of Companies.